Anzeige
Mehr »
Lynx Broker
Login
Mittwoch, 20.11.2019 Börsentäglich über 12.000 News von 616 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 885823 ISIN: US3755581036 Ticker-Symbol: GIS 
Tradegate
20.11.19
13:06 Uhr
58,36 Euro
-0,33
-0,56 %
1-Jahres-Chart
GILEAD SCIENCES INC Chart 1 Jahr
5-Tage-Chart
GILEAD SCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
58,43
58,51
13:34
58,47
58,65
13:34

Aktuelle News zur GILEAD SCIENCES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoIs Gilead Stock A Buy Right Now? Here's What Earnings, Chart Show85
Do3 Big Stock Charts for Thursday: Gilead Sciences, DocuSign and Western Digital33
13.11.Galapagos NV: Transparency notification - Gilead holds 25.10% of Galapagos shares192Mechelen, Belgium; 13 November 2019; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Gilead Sciences, Inc. Pursuant to Belgian...
► Artikel lesen
GILEAD SCIENCES Aktien jetzt im kostenlosen Demokonto handeln!
12.11.Gilead Sciences braucht mehr Katalysatoren!1.317Atlanta (www.aktiencheck.de) - Gilead Sciences-Aktienanalyse der Analystin Robyn Karnauskas von SunTrust Robinson Humphrey: Laut einer Aktienanalyse empfiehlt Robyn Karnauskas, Analystin bei SunTrust...
► Artikel lesen
11.11.Will Its HIV Lineup Save Gilead Sciences?49
11.11.AASLD: Gilead wants to move the needle for fatty liver therapies28
08.11.United States files complaint against Gilead for patent infringement22
08.11.Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR'd Kidneys & More13
08.11.US Files Complaint Against Gilead Sciences For Patent Infringement287FOSTER CITY (dpa-AFX) - The United States government has filed a lawsuit against Gilead Sciences, alleging that the biopharmaceutical company's two HIV drugs, Truvada and Descovy, infringe...
► Artikel lesen
08.11.Gilead Presents Data on Investigational HIV-1 Capsid Inhibitor GS-6207 as a Potential Component of Long-Acting HIV Therapy344- Phase 1 Results Support Up to Six-month Dosing Interval and Advancement Into Later-Stage Clinical Trials - Gilead Sciences, Inc. (NASDAQ:GILD) today announced data on GS-6207, an investigational...
► Artikel lesen
08.11.Gilead Announces New Data from Viral Hepatitis Research Programs at The Liver Meeting 20191.000-- Data Demonstrate Reductions in Hepatocellular Carcinoma in Hepatitis B (HBV) Patients Treated with Vemlidy -- -- Improved Markers of Bone and Renal Safety Also Seen with Vemlidy in Separate...
► Artikel lesen
08.11.Is The Future Finally Looking Up For Gilead Sciences?31
07.11.US sues Gilead over HIV patent infringements19
07.11.Trump administration sues Gilead Sciences over HIV prevention patents29
07.11.Unsuccessful in licensing talks, feds sue Gilead over PrEP-focused HIV patent15
07.11.Sierra Oncology and Gilead Sciences Agree on Amendments to Asset Purchase Agreement for Momelotinib35
07.11.HHS is taking Gilead to court and seeking damages for infringing government HIV patents31
06.11.Galapagos NV: Galapagos increases share capital through warrant exercise by Gilead852Mechelen, Belgium; 6 November 2019, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from a warrant exercise by Gilead. On 1 November...
► Artikel lesen
06.11.Gilead touts new data for fast-growing Biktarvy as older HIV meds show some cracks12
06.11.Gilead HIV meds show sustained benefit in late-stage studies10
Seite:  Weiter >>
482 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
16,12,118